Evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patients

Objectives: To implement and assess hospital-based pharmaceutical care services for patients with asthma. Methods: A prospective, randomized, controlled study was conducted in Shaab teaching hospital, Khartoum, Sudan. Patients were allocated randomly either in the intervention group (60) or control group (40) patients. The drug therapy of asthma for the patients in the intervention group was reviewed by a trained pharmacist, and interventions were suggested to the attending physicians for the identified problems. Intervention patients received comprehensive medication counselling and asthma education every 2 weeks, while the control group received the routine medical consultation and dispensing services. The outcome measures were recorded using structured forms at baseline and monitored during a follow-up of every two weeks for 6 months in both groups. Data were analyzed using SPSS version 13, level of significance was p<0.05. Results: At the end of the study period the mean reduction in frequency of acute attacks (1.91; SD=0.18 vs. 1.0; SD=0.14; p=0.03), nocturnal asthma symptoms (3.5; SD=0.3 vs. 1.1; SD=0.2; p=0.02) and frequency of using inhaled ß2 agonists per week (19.9; SD= 2.1 vs. 3.3; SD=0.3; p=0.01) were significantly greater in the intervention group compared to control. A significant mean reduction (p=0.002) in the days of sickness/week was in the intervention group, while in control group there was an increase in mean days of sickness/week. The intervention group showed a significant greater improvement in the score for assessing the inhalation technique (p<0.001), patient’s knowledge about asthma (p<0.001), and its drug-therapy (p=0.01) compared with control. Conclusion: The present findings suggest that pharmacist’s intervention can have positive impact on asthma-related outcomes in patients.

Saved in:
Bibliographic Details
Main Authors: Abdelhamid,Elkhansa, Awad,Abdelmoneim, Gismallah,Abdellatif
Format: Digital revista
Language:English
Published: Centro de Investigaciones y Publicaciones Farmacéuticas 2008
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2008000100005
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1885-642X2008000100005
record_format ojs
spelling oai:scielo:S1885-642X20080001000052017-01-20Evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patientsAbdelhamid,ElkhansaAwad,AbdelmoneimGismallah,Abdellatif Asthma Pharmacists Pharmaceutical Services Sudan Objectives: To implement and assess hospital-based pharmaceutical care services for patients with asthma. Methods: A prospective, randomized, controlled study was conducted in Shaab teaching hospital, Khartoum, Sudan. Patients were allocated randomly either in the intervention group (60) or control group (40) patients. The drug therapy of asthma for the patients in the intervention group was reviewed by a trained pharmacist, and interventions were suggested to the attending physicians for the identified problems. Intervention patients received comprehensive medication counselling and asthma education every 2 weeks, while the control group received the routine medical consultation and dispensing services. The outcome measures were recorded using structured forms at baseline and monitored during a follow-up of every two weeks for 6 months in both groups. Data were analyzed using SPSS version 13, level of significance was p<0.05. Results: At the end of the study period the mean reduction in frequency of acute attacks (1.91; SD=0.18 vs. 1.0; SD=0.14; p=0.03), nocturnal asthma symptoms (3.5; SD=0.3 vs. 1.1; SD=0.2; p=0.02) and frequency of using inhaled ß2 agonists per week (19.9; SD= 2.1 vs. 3.3; SD=0.3; p=0.01) were significantly greater in the intervention group compared to control. A significant mean reduction (p=0.002) in the days of sickness/week was in the intervention group, while in control group there was an increase in mean days of sickness/week. The intervention group showed a significant greater improvement in the score for assessing the inhalation technique (p<0.001), patient’s knowledge about asthma (p<0.001), and its drug-therapy (p=0.01) compared with control. Conclusion: The present findings suggest that pharmacist’s intervention can have positive impact on asthma-related outcomes in patients.Centro de Investigaciones y Publicaciones FarmacéuticasPharmacy Practice (Granada) v.6 n.1 20082008-03-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2008000100005en
institution SCIELO
collection OJS
country España
countrycode ES
component Revista
access En linea
databasecode rev-scielo-es
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Abdelhamid,Elkhansa
Awad,Abdelmoneim
Gismallah,Abdellatif
spellingShingle Abdelhamid,Elkhansa
Awad,Abdelmoneim
Gismallah,Abdellatif
Evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patients
author_facet Abdelhamid,Elkhansa
Awad,Abdelmoneim
Gismallah,Abdellatif
author_sort Abdelhamid,Elkhansa
title Evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patients
title_short Evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patients
title_full Evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patients
title_fullStr Evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patients
title_full_unstemmed Evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patients
title_sort evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patients
description Objectives: To implement and assess hospital-based pharmaceutical care services for patients with asthma. Methods: A prospective, randomized, controlled study was conducted in Shaab teaching hospital, Khartoum, Sudan. Patients were allocated randomly either in the intervention group (60) or control group (40) patients. The drug therapy of asthma for the patients in the intervention group was reviewed by a trained pharmacist, and interventions were suggested to the attending physicians for the identified problems. Intervention patients received comprehensive medication counselling and asthma education every 2 weeks, while the control group received the routine medical consultation and dispensing services. The outcome measures were recorded using structured forms at baseline and monitored during a follow-up of every two weeks for 6 months in both groups. Data were analyzed using SPSS version 13, level of significance was p<0.05. Results: At the end of the study period the mean reduction in frequency of acute attacks (1.91; SD=0.18 vs. 1.0; SD=0.14; p=0.03), nocturnal asthma symptoms (3.5; SD=0.3 vs. 1.1; SD=0.2; p=0.02) and frequency of using inhaled ß2 agonists per week (19.9; SD= 2.1 vs. 3.3; SD=0.3; p=0.01) were significantly greater in the intervention group compared to control. A significant mean reduction (p=0.002) in the days of sickness/week was in the intervention group, while in control group there was an increase in mean days of sickness/week. The intervention group showed a significant greater improvement in the score for assessing the inhalation technique (p<0.001), patient’s knowledge about asthma (p<0.001), and its drug-therapy (p=0.01) compared with control. Conclusion: The present findings suggest that pharmacist’s intervention can have positive impact on asthma-related outcomes in patients.
publisher Centro de Investigaciones y Publicaciones Farmacéuticas
publishDate 2008
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2008000100005
work_keys_str_mv AT abdelhamidelkhansa evaluationofahospitalpharmacybasedpharmaceuticalcareservicesforasthmapatients
AT awadabdelmoneim evaluationofahospitalpharmacybasedpharmaceuticalcareservicesforasthmapatients
AT gismallahabdellatif evaluationofahospitalpharmacybasedpharmaceuticalcareservicesforasthmapatients
_version_ 1755941106801967104